Usana Health Sciences Inc Stock Price, News & Analysis

USANA Health Sciences, Inc. (NYSE:USNA) will announce its second quarter results on July 27, 2021, after market close. Following this, a Management Commentary will be available on its website. A conference call for analysts and investors is scheduled for July 28, 2021, at 11:00 a.m. ET. USANA specializes in developing high-quality nutritional supplements and personal care products sold directly to consumers globally in various markets including the US, Canada, and several countries in Asia and Europe.

USANA received multiple prestigious international awards in recognition of corporate excellence and product quality. Notably, the company was honored with three awards at the Asia Pacific Stevie Awards, including Gold for Innovation in Product Design. In 2020, USANA reported a 7.0% increase in global net sales, totaling $1.135 billion. The company also won accolades in the Korea Medical Healthcare Awards and was named 'Most Trusted Provider of Nutritional Products' at the Global Health and Pharma Excellence Awards. These achievements reflect USANA's growth and innovation across its global market.

On June 21, 2021, Kevin Guest, CEO of USANA Health Sciences (NYSE: USNA), emphasized the importance of harmony in the workplace in a statement celebrating World Day of Music. Guest shared three steps to enhance team morale through music: playing nostalgic songs, singing favorite tunes aloud, and collaborating with colleagues in group singing. He noted that post-pandemic, restoring workplace harmony is crucial for productivity. His insights are elaborated in his book, All the Right Reasons, which supports feeding two million hungry children through its proceeds.

USANA Chairman and CEO Kevin Guest has been elected as the chairman of the board of the Direct Selling Association (DSA) for a one-year term. Recognized for his leadership in the direct sales industry, Guest aims to enhance the sector's integrity and innovation. Under his guidance, USANA has experienced record sales growth and a focus on digital transformation. The DSA supports a market generating $40.1 billion in retail sales and includes 7.7 million entrepreneurs in the U.S.

USANA Health Sciences has launched its Active Nutrition product line on June 15, 2021, in the U.S., Canada, and Mexico. This line includes seven new science-based products aimed at enhancing overall health, from weight management to digestive health. Notable offerings include Nutrimeal Active, Digestive Health Protein Drink, and Electrolyte Replacement Mix, all formulated to support various health goals. USANA emphasizes a holistic approach to wellness that prioritizes gut health and overall well-being. The launch reflects USANA's commitment to providing high-quality nutritional products.

USANA's Director of Human Resources, Sheena Blauvelt, has received the HR Achievement Award from Utah Business Magazine for her exceptional contributions to human resources. This recognition highlights her efforts in enhancing employee development and recruitment strategies at USANA. Sheena has been pivotal in implementing leadership programs since joining in 2017 and recently became the Director of Human Resources. The award event is scheduled for June 8, 2021. USANA, listed as USNA, emphasizes its commitment to quality in nutritional products.

USANA Health Sciences, along with its Chinese subsidiary BabyCare, has formed a research collaboration with Beijing University of Chinese Medicine (BUCM). This partnership aims to integrate Traditional Chinese Medicine (TCM) with modern nutritional science to enhance health and wellness globally. Key areas of research include the effectiveness of TCM in replenishing qi, evaluating TCM ingredients, and developing targeted nutritional products. USANA also gains commercialization rights for any resulting products from this collaboration. A signing ceremony was held on May 19, 2021.

USANA Health Sciences reported strong financial results for Q1 2021, with a 15.5% year-over-year increase in net sales to $308.0 million and a 17.9% rise in diluted EPS to $1.45.

The company repurchased 721,000 shares for $69.5 million and raised its 2021 outlook for net sales and diluted EPS. Active customers grew 7.7% to 617,000, showing strong demand across all regions, particularly in Asia Pacific.